Despite Its Nascent Technology, MicroRNA Field Adds New Players

In the past 12 months alone, at least three new companies have been launched to develop miRNA drugs, including Miragen Therapeutics, Mirna Therapeutics, and Regulus Therapeutics.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories